RYSTIGGO 140 MG/ML SOLUCION INYECTABLE
RYSTIGGO 140 MG/ML SOLUCION INYECTABLE
Commercialized
Register Number
1231780001
Prescription Type
Uso Hospitalario
Authorization Date
Feb 5, 2024
Dosage Form
SOLUCIÓN INYECTABLE
Route: VÍA SUBCUTÁNEA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1231780001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
ROZANOLIXIZUMABActive
Quantity: 280 mg
Name: ROZANOLIXIZUMAB
ATC CLASSIFICATION (3)
L04A
L04AG
L04AG16